The "central vein sign" to differentiate multiple sclerosis from migraine
- PMID: 39834045
- DOI: 10.1111/head.14902
The "central vein sign" to differentiate multiple sclerosis from migraine
Abstract
Objective: To investigate, in two cohorts including patients with multiple sclerosis (MS) and migraine, (i) the prevalence of the "central vein sign" (CVS), (ii) the spatial distribution of positive CVS (CVS+) lesions, (iii) the threshold of CVS+ lesions able to distinguish MS from migraine with high sensitivity and specificity.
Methods: A total of 70 patients with MS/clinically isolated syndrome and 50 age- and sex-matched patients with migraine underwent a 3-T magnetic resonance imaging scan. The CVS was evaluated according to current guidelines, excluding eight patients with migraine who did not show white matter (WM) lesions. A receiver operating characteristic curve analysis was performed to identify the best threshold in terms of proportion of CVS+ lesions and the absolute number of CVS+ lesions able to differentiate MS from migraine.
Results: Lesion volume was different between CVS+ and CVS negative lesions (median 1043 vs. 176.5 mm3 for MS cohort; median 35.1 vs. 52.2 mm3 for migraine cohort; p < 0.001 for all). A higher proportion of CVS+ lesions was associated with a higher probability of being diagnosed as MS (adjusted odds ratio 1.09, 95% confidence interval [CI] 1.04-1.14; p < 0.001). CVS+ lesion volume and number were higher in MS with respect to migraine, both considering the whole brain and its subregions (p < 0.001). The proportion of CVS+ lesions in juxtacortical and infratentorial areas was higher in MS than in migraine (p = 0.015 and p = 0.034, respectively). The best CVS proportion-based threshold able to differentiate MS from migraine was 35.0% (sensitivity 97.1%, specificity 85.7%) with an area under the curve of 0.95 (95% CI 0.90-1.00). The "select 6" rule seemed to be preferable in terms of specificity with respect to the "select 3" rule.
Conclusions: A CVS proportion-based threshold of 35.0% is capable of distinguishing MS from migraine with high sensitivity and specificity. The "select 6" algorithm may be useful in the clinical setting.
Keywords: biomarker; central vein sign; diagnosis; migraine; multiple sclerosis.
© 2025 American Headache Society.
References
REFERENCES
-
- Calabrese M, Gasperini C, Tortorella C, et al. “Better explanations” in multiple sclerosis diagnostic workup: a 3‐year longitudinal study. Neurology. 2019;92(22):e2527‐e2537.
-
- Solomon AJ, Bourdette DN, Cross AH, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology. 2016;87(13):1393‐1399.
-
- Dobrynina LA, Suslina AD, Gubanova MV, et al. White matter hyperintensity in different migraine subtypes. Sci Rep. 2021;11(1):10881.
-
- Eikermann‐Haerter K, Huang SY. White matter lesions in migraine. Am J Pathol. 2021;191(11):1955‐1962.
-
- Sati P, Oh J, Todd Constable R, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the north American imaging in multiple sclerosis cooperative. Nat Rev Neurol. 2016;12(12):714‐722.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
